查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1543674

全球重組化學品市場規模研究（依產品類型、技術、應用和區域預測 2022-2032）

Global Recombinant Chemicals Market Size Study, by Product Type, by Technology, by Application, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球重組化學品市場價值約為 29 億美元，預計在 2024-2032 年預測期內將以超過 7.8% 的健康成長率成長。透過基因工程技術生產的重組化學物質包括重組蛋白、DNA 和胜肽。重組蛋白是由克隆基因產生的多肽，因其高純度、特異性、高效、安全、客製化、可擴展性和一致性等優點而廣泛應用於醫學、研究和生物技術等領域。重組蛋白用於疫苗開發、治療、診斷以及藥物發現和開發。它們包括細胞激素、酵素、荷爾蒙、凝血因子、生長因子、單株抗體 (mAb) 和抗體相關產品。重組蛋白疫苗被認為比活病毒衍生的疫苗更安全，因為它們是非複製的並且缺乏傳染性成分。

重組蛋白疫苗需求的成長正在顯著推動重組化學品的市場價值。重組蛋白疫苗構成了一個經過驗證且完善的疫苗開發平台，由於對基於重組蛋白的 SARS-CoV-2 疫苗的需求不斷增加，其需求特別大，從而增加了對 DNA 衍生化學品的需求。遺傳性疾病的流行也推動了重組化學品市場的發展。透過重組 DNA 技術生產的醫藥產品徹底改變了各種遺傳性疾病的治療和管理。重組化學品市場的主要參與者正在生產用於研究抗體和酵素結合位點的高純度重組產品，以及新型小型療法、藥劑和疫苗。

重組 DNA 技術涉及連接兩個不同物種的 DNA 分子，該技術在醫藥和生物技術產品（包括營養保健品）的生產中越來越受到關注。 Elelyso 等產品含有活性物質 taliglucerase alfa，採用重組 DNA 技術生產，用於治療 1 型戈謝病等遺傳性疾病。

全球重組化學品市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 2023年，北美將成為主導地區。這種主導地位主要是由先進的生物技術基礎設施、研發方面的大量投資以及大型製藥和生物技術公司的存在所推動的。此外，政府措施的大力支持和對生物製藥的高需求也有助於北美在該市場的領先地位。另一方面，亞太地區是重組化學品成長最快的市場。該地區的快速成長得益於醫療保健支出的增加、生物技術產業的發展以及生命科學研究投資的增加。中國和印度等國家由於其不斷擴大的製藥業、有利的政府政策以及對精準醫療的日益關注而處於這一成長的前沿。此外，熟練勞動力的可用性和新生物技術新創公司的成立進一步加速了亞太地區的市場擴張。

目錄

第 1 章：全球重組化學品市場執行摘要

  • 全球重組化學品市場規模及預測（2022-2032）
  • 區域概要
  • 分部摘要
    • 依產品類型
    • 依技術
    • 按申請
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章：全球重組化學品市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包含與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者的角度）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球重組化學品市場動態

  • 市場促進因素
    • 對重組蛋白疫苗的需求增加
    • 遺傳性疾病盛行率激增
  • 市場挑戰
    • 經濟不確定性和成本擔憂
  • 市場機會
    • 重組 DNA 技術的創新
    • 應用領域的擴展

第 4 章：全球重組化學品市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球重組化學品市場規模與預測：依產品類型 - 2022-2032

  • 細分儀表板
  • 全球重組化學品市場：2022 年和 2032 年產品類型收入趨勢分析
    • 重組蛋白
    • 重組DNA
    • 重組胜肽
    • 其他

第 6 章：全球重組化學品市場規模與預測：依技術分類 - 2022-2032

  • 細分儀表板
  • 全球重組化學品市場：2022 年和 2032 年技術收入趨勢分析
    • 微生物表現系統
    • 哺乳動物細胞表現系統
    • 酵母表現系統
    • 昆蟲細胞表現系統
    • 無細胞表現系統

第 7 章：全球重組化學品市場規模與預測：依應用分類 - 2022-2032

  • 細分儀表板
  • 全球重組化學品市場：2022 年和 2032 年應用收入趨勢分析
    • 藥物開發
    • 疫苗生產
    • 療法
    • 細胞株開發
    • 農業
    • 食品和飲料
    • 其他

第 8 章：全球重組化學品市場規模與預測：按地區 - 2022-2032

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • Genentech, Inc.
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • Amgen Inc.
    • Biogen
    • Pfizer, Inc.
    • Novartis AG
    • Merck & Co.
    • Sanofi
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson Services, Inc.
    • Bayer AG
    • Mitsubishi Chemical Group
    • Bharat Serums and Vaccines (BSV)
    • Serum Institute of India
    • University of Sao Paulo (USP)
    • Oswaldo Cruz Foundation (FIOCRUZ)

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032. Recombinant chemicals, produced through genetic engineering techniques, include recombinant proteins, DNAs, and peptides. Recombinant proteins are polypeptides produced from cloned genes and are widely employed in fields such as medicine, research, and biotechnology due to their advantages such as high purity, specificity, efficiency, safety, customization, scalability, and consistency. Recombinant proteins are used in vaccine development, therapeutics, diagnostics, and drug discovery and development. They include cytokines, enzymes, hormones, blood clotting factors, growth factors, monoclonal antibodies (mAbs), and antibody-related products. Recombinant protein vaccines are considered safer than vaccines derived from live viruses as they are non-replicating and lack infectious components.

The rise in demand for recombinant protein vaccines is significantly driving the market value of recombinant chemicals. Recombinant protein vaccines, which constitute a proven and well-established vaccine development platform, are particularly in demand due to the increased need for recombinant protein-based SARS-CoV-2 vaccines, thereby augmenting the demand for DNA-derived chemicals. The prevalence of genetic disorders is also fueling the recombinant chemicals market development. Medicinal products produced through recombinant DNA technology have revolutionized the treatment and management of various genetic disorders. Key players operating in the recombinant chemicals market are producing high-purity recombinant products for studying antibody and enzyme binding sites, as well as novel small therapeutics, drug agents, and vaccines.

Recombinant DNA technology, which involves the joining of DNA molecules from two different species, is gaining traction in the production of pharmaceutical and biotechnological products, including nutraceuticals. Products such as Elelyso, which contains the active substance taliglucerase alfa, are produced using recombinant DNA technology for the treatment of genetic disorders like type 1 Gaucher disease.

Key regions considered for the global Recombinant Chemicals Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. In 2023, North America stands out as the dominating region. This dominance is primarily driven by the presence of advanced biotechnology infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotech companies. Additionally, strong support from government initiatives and a high demand for biopharmaceuticals contribute to North America's leading position in this market. On the other hand, the Asia-Pacific region is the fastest-growing market for recombinant chemicals. The rapid growth in this region is fueled by increasing healthcare expenditures, a growing biotech industry, and rising investments in life sciences research. Countries like China and India are at the forefront of this growth due to their expanding pharmaceutical sectors, favorable government policies, and a rising focus on precision medicine. Additionally, the availability of a skilled workforce and the establishment of new biotech startups further accelerate the market expansion in the Asia-Pacific region.

Major market players included in this report are:

  • Genentech, Inc.
  • Amgen Inc.
  • Biogen
  • Pfizer, Inc.
  • Novartis AG
  • Merck & Co.
  • Sanofi
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • Mitsubishi Chemical Group
  • Bharat Serums and Vaccines (BSV)
  • Serum Institute of India
  • University of Sao Paulo (USP)
  • Oswaldo Cruz Foundation (FIOCRUZ)

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Recombinant Proteins
  • Recombinant DNAs
  • Recombinant Peptides
  • Others

By Technology:

  • Microbial Expression Systems
  • Mammalian Cell Expression Systems
  • Yeast Expression Systems
  • Insect Cell Expression Systems
  • Cell-free Expression Systems

By Application:

  • Drug Development
  • Vaccine Production
  • Therapeutics
  • Cell Line Development
  • Agriculture
  • Food and Beverage
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2034

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Recombinant Chemicals Market Executive Summary

  • 1.1. Global Recombinant Chemicals Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Technology
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Recombinant Chemicals Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Recombinant Chemicals Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rise in Demand for Recombinant Protein Vaccines
    • 3.1.2. Surge in Prevalence of Genetic Disorders
  • 3.2. Market Challenges
    • 3.2.1. Economic Uncertainty and Cost Concerns
  • 3.3. Market Opportunities
    • 3.3.1. Innovations in Recombinant DNA Technology
    • 3.3.2. Expansion of Application Areas

Chapter 4. Global Recombinant Chemicals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Recombinant Chemicals Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Recombinant Chemicals Market: Product Type Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 5.2.1. Recombinant Proteins
    • 5.2.2. Recombinant DNAs
    • 5.2.3. Recombinant Peptides
    • 5.2.4. Others

Chapter 6. Global Recombinant Chemicals Market Size & Forecasts by Technology 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Recombinant Chemicals Market: Technology Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 6.2.1. Microbial Expression Systems
    • 6.2.2. Mammalian Cell Expression Systems
    • 6.2.3. Yeast Expression Systems
    • 6.2.4. Insect Cell Expression Systems
    • 6.2.5. Cell-free Expression Systems

Chapter 7. Global Recombinant Chemicals Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Recombinant Chemicals Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
    • 7.2.1. Drug Development
    • 7.2.2. Vaccine Production
    • 7.2.3. Therapeutics
    • 7.2.4. Cell Line Development
    • 7.2.5. Agriculture
    • 7.2.6. Food and Beverage
    • 7.2.7. Others

Chapter 8. Global Recombinant Chemicals Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Recombinant Chemicals Market
    • 8.1.1. U.S. Recombinant Chemicals Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Recombinant Chemicals Market
  • 8.2. Europe Recombinant Chemicals Market
    • 8.2.1. UK Recombinant Chemicals Market
    • 8.2.2. Germany Recombinant Chemicals Market
    • 8.2.3. France Recombinant Chemicals Market
    • 8.2.4. Spain Recombinant Chemicals Market
    • 8.2.5. Italy Recombinant Chemicals Market
    • 8.2.6. Rest of Europe Recombinant Chemicals Market
  • 8.3. Asia-Pacific Recombinant Chemicals Market
    • 8.3.1. China Recombinant Chemicals Market
    • 8.3.2. India Recombinant Chemicals Market
    • 8.3.3. Japan Recombinant Chemicals Market
    • 8.3.4. Australia Recombinant Chemicals Market
    • 8.3.5. South Korea Recombinant Chemicals Market
    • 8.3.6. Rest of Asia Pacific Recombinant Chemicals Market
  • 8.4. Latin America Recombinant Chemicals Market
    • 8.4.1. Brazil Recombinant Chemicals Market
    • 8.4.2. Mexico Recombinant Chemicals Market
    • 8.4.3. Rest of Latin America Recombinant Chemicals Market
  • 8.5. Middle East & Africa Recombinant Chemicals Market
    • 8.5.1. Saudi Arabia Recombinant Chemicals Market
    • 8.5.2. South Africa Recombinant Chemicals Market
    • 8.5.3. Rest of Middle East & Africa Recombinant Chemicals Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Genentech, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Amgen Inc.
    • 9.3.3. Biogen
    • 9.3.4. Pfizer, Inc.
    • 9.3.5. Novartis AG
    • 9.3.6. Merck & Co.
    • 9.3.7. Sanofi
    • 9.3.8. F. Hoffmann-La Roche AG
    • 9.3.9. Johnson & Johnson Services, Inc.
    • 9.3.10. Bayer AG
    • 9.3.11. Mitsubishi Chemical Group
    • 9.3.12. Bharat Serums and Vaccines (BSV)
    • 9.3.12. Serum Institute of India
    • 9.3.14. University of Sao Paulo (USP)
    • 9.3.15. Oswaldo Cruz Foundation (FIOCRUZ)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes